Skip to main content

Clinical Trials Using Anti-NKG2A Monoclonal Antibody Sym025

Review the clinical trials studying anti-nkg2a monoclonal antibody sym025 on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-2 of 2

Phase 1b/2 Platform Study of Select Immunotherapy Combinations in Participants With Advanced Non-small Cell Lung Cancer (NSCLC)
Status: Active
Location: Ohio State University Comprehensive Cancer Center, Columbus, Ohio
A Study to Evaluate the Safety and the Activity of S095029 as Part of Combination Therapy in Advanced Gastroesophageal Junction/Gastric Cancers.
Status: Active
Location: See ClinicalTrials.gov